Difference between revisions of "Team:Minnesota/Registry"
PatrickHolec (Talk | contribs) |
PatrickHolec (Talk | contribs) |
||
Line 775: | Line 775: | ||
<i> The Registry of Standard Biological Parts has been a longstanding partner of iGEM. The promotion of synthetic biology communication and cooperation have become tenants of every iGEM team. The database was an incredible step forward in biological research and standardization. And for this reason, we must now reevaluate the registry. </i><br> | <i> The Registry of Standard Biological Parts has been a longstanding partner of iGEM. The promotion of synthetic biology communication and cooperation have become tenants of every iGEM team. The database was an incredible step forward in biological research and standardization. And for this reason, we must now reevaluate the registry. </i><br> | ||
− | <b><font size="4"> Moore's Law and Biology </font></b><br> | + | <b><font size="4"><center> Moore's Law and Biology </font></b><br></center> |
<br> | <br> | ||
Moore’s Law is a principle developed in 1975 claiming the maximum number of transistors per microchip doubles every two years. Analogous to the technological limits in computer engineering, biology has seen a similar trend in the cost of sequencing and synthesizing DNA. The high cost of synthetic biology is what initially drove the movement to physical databases of biological parts. For example, a gene segment costing $800 when the Registry of Biological Parts was conceived, while only costing around $30 by modern standards. In the last decade and a half, synthesis prices have halved approximately every 2.5 years. <br> | Moore’s Law is a principle developed in 1975 claiming the maximum number of transistors per microchip doubles every two years. Analogous to the technological limits in computer engineering, biology has seen a similar trend in the cost of sequencing and synthesizing DNA. The high cost of synthetic biology is what initially drove the movement to physical databases of biological parts. For example, a gene segment costing $800 when the Registry of Biological Parts was conceived, while only costing around $30 by modern standards. In the last decade and a half, synthesis prices have halved approximately every 2.5 years. <br> | ||
Line 784: | Line 784: | ||
<img src="https://static.igem.org/mediawiki/2015/a/a9/Registry_1.png" width=100% height=75%> | <img src="https://static.igem.org/mediawiki/2015/a/a9/Registry_1.png" width=100% height=75%> | ||
<br> | <br> | ||
+ | |||
+ | <i><center><u><font size="3">• </font>Today's Registry</u></i></center> | ||
Maybe there still is value in the registry, and maybe it does save groups synthesis costs and time. After all, current saves researchers $325 on average a day. But when we return to this conversation in 5 years and the savings is only about $80 a day? The National Science Foundation (NSF, $37 million over 10 years), and Defense Advanced Research Projects Agency (DARPA, undisclosed grant), and National Institutes of Health (NIH, undisclosed grant) funnel hefty grants as well as the International Genetically Engineered Machines (iGEM) competition to develop and contribute to the physical stock of parts. Should we be investing in this type of technology? <br> | Maybe there still is value in the registry, and maybe it does save groups synthesis costs and time. After all, current saves researchers $325 on average a day. But when we return to this conversation in 5 years and the savings is only about $80 a day? The National Science Foundation (NSF, $37 million over 10 years), and Defense Advanced Research Projects Agency (DARPA, undisclosed grant), and National Institutes of Health (NIH, undisclosed grant) funnel hefty grants as well as the International Genetically Engineered Machines (iGEM) competition to develop and contribute to the physical stock of parts. Should we be investing in this type of technology? <br> | ||
Line 792: | Line 794: | ||
− | + | ||
− | + | ||
<br> | <br> | ||
Insulin is a hormone produced by the pancreas that removes glucose from the blood. In healthy individuals, excess glucose is readily removed from the blood stream by a proportional production of insulin. In persons with diabetes mellitus however; the body is either resistant to insulin, or it has a reduced capacity to produce insulin. Those individuals require an external source of insulin. | Insulin is a hormone produced by the pancreas that removes glucose from the blood. In healthy individuals, excess glucose is readily removed from the blood stream by a proportional production of insulin. In persons with diabetes mellitus however; the body is either resistant to insulin, or it has a reduced capacity to produce insulin. Those individuals require an external source of insulin. | ||
Line 799: | Line 800: | ||
<br> | <br> | ||
− | <img src=" | + | <img src="https://static.igem.org/mediawiki/2015/4/45/Registry_2.png" width=100% height=75%> |
<br> | <br> | ||
− | <i><u><font size="3">• </font> | + | <i><u><center><font size="3">• </font> The Best of the Registry </u></i></center> |
<br> | <br> | ||
− | + | ||
− | + | ||
<br> | <br> | ||
− | <img src=" | + | <img src="https://static.igem.org/mediawiki/2015/1/17/Registry_3.png" width=100% height=75%> |
<br> | <br> | ||
Revision as of 08:42, 18 September 2015